Study of treatment for pyoderma gangrenosum patients.

Trial Profile

Study of treatment for pyoderma gangrenosum patients.

Completed
Phase of Trial: Phase IV

Latest Information Update: 08 Feb 2017

At a glance

  • Drugs Ciclosporin (Primary) ; Prednisolone (Primary)
  • Indications Pyoderma gangrenosum
  • Focus Therapeutic Use
  • Acronyms STOP-GAP
  • Most Recent Events

    • 22 Jun 2013 Status changed from active, no longer recruiting to completed as reported by United Kingdom Clinical Research Network.
    • 07 Dec 2012 Status changed from recruiting to active, no longer recruiting as reported by United Kingdom Clinical Research Network record.
    • 05 Dec 2012 Accrual to date is 135% according to United Kingdom Clinical Research Network record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top